The etiology and management of pregnancy rhinitis

American Journal of Respiratory Medicine

Volumn 2, Issue 6, 2003, Pages 469-475

  Ellegård, Eva K ^a  

^a Kungsbacka Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BUDESONIDE; CORTICOSTEROID; DECONGESTIVE AGENT; ESTROGEN; FLUTICASONE PROPIONATE; HUMAN GROWTH HORMONE; PLACEBO; PLACENTAL PEPTIDE HORMONE; PROGESTERONE; PROLACTIN; SODIUM CHLORIDE;

ALLERGY; ARTICLE; CIGARETTE SMOKING; DELIVERY; DERMATOPHAGOIDES; DIFFERENTIAL DIAGNOSIS; DRUG INDICATION; ECHOGRAPHY; ENDOSCOPY; FEMALE; GESTATION PERIOD; HUMAN; LAVAGE; NOSE CARTILAGE; NOSE CONGESTION; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; PROBABILITY; RADIOGRAPHY; RESPIRATORY TRACT EXAMINATION; RESPIRATORY TRACT INFECTION; RHINITIS; RISK FACTOR; SAFETY; SENSITIZATION; SINUSITIS; SYMPTOM; TREATMENT FAILURE; XEROSTOMIA;

EID: 0348155677     PISSN: 11756365     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03256674     Document Type: Article

References (55)

1. Bresgen M. Der chronische nasen- and rachen-katarrh. Wien: Urban & Schwarzenberg, 1881
2. MacKenzie JN. Irritation of the sexual apparatus as an etiological factor in the production of nasal disease. Am J Med Sci 1884; 87: 360-5
3. MacKenzie JN. The physiological and pathological relations between the nose and the sexual apparatus of man. Alienist Neurol 1898; 19: 219-39
4. Endriss G. Die bisherigen Beobachtungen von physiologische und pathologische Bezieungen der obern Luftvage den Sexualorganismus. Würzburg: 1892
5. Mohan M. Incidence of vasomotor rhinitis during pregnancy. Arch Otolaryngol 1943; 37: 699-709
6. Ruskin SL. Rationale of estrogen therapy of primary atrophic rhinitis (ozena). Arch Otolaryngol 1942; 36: 632-49
7. Bernheimer LB, Soskin S. Mechanism of effect of estrogen on nasal mucosa in atrophic rhinitis. Arch Otolaryngol 1940; 32: 957-9
8. Holmes TH, Goodell H, Wolf S, et al. The relation of nasal to sexual function. The nose: an experimental study of reactions within the nose in human subjects during varying life experiences. Springfield (IL): Charles C Thomas, 1950: 89-100
9. Mabry RL. Intranasal steroid injection during pregnancy. South Med J 1980; 73: 1176-9
10. Toppozada H, Michaels L, Toppozada M, et al. The human respiratory nasal mucosa in pregnancy. J Laryngol Otol 1982; 96: 613-26
11. Bende M, Hallgårde U, Sjögren C. Occurrence of nasal congestion during pregnancy. Am J Rhinol 1989; 3: 217-9
12. Ellegård E, Karlsson G. Nasal congestion during pregnancy. Clin Otolaryngol 1999; 24: 307-11
13. Toppozada H, Toppozada M, El-Ghazzawi I, et al. The human respiratory nasal mucosa in females using contraceptive pills. J Laryngol Otol 1984; 98: 43-51
14. Toppozada H, Michaels L, Toppozada M, et al. The human nasal mucosa in the menstrual cycle. J Laryngol Otol 1981; 95: 1237-47
15. Ellegård E, Karlsson G. Nasal congestion during the menstrual cycle. Clin Otolaryngol 1994; 19 (5): 400-3
16. Schatz M, Hoffman C. Interrelationships between asthma and pregnancy: clinical and mechanistic considerations. Clin Rev Allergy 1987; 5: 301-15
17. Schatz M. Asthma during pregnancy: interrelationships and management. Ann Allergy 1992; 68: 123-33
18. Schatz M, Zeiger RS. Diagnosis and management of rhinitis during pregnancy. Allergy Proc 1988; 9: 545-54
19. Ellegård E, Oscarsson J, Bougoussa M, et al. Serum level of placental growth hormone is raised in pregnancy rhinitis. Arch Otolaryngol Head Neck Surg 1998; 124: 439-43
20. Schatz M, Zeiger RS. Asthma and allergy in pregnancy. Clin Perinatol 1997; 24: 407-32
21. Eriksson L, Frankenne F, Eden S, et al. Growth hormone 24-h serum profiles during pregnancy: lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol 1989; 96: 949-53
22. Igout A, Frankenne F, L'Hermite-Baleriaux M, et al. Somatogenic and lactogenic activity of the recombinant 22 kDa isoform of human placental growth hormone. Growth Regul 1995; 5: 60-5
23. Furlanetto RW. Insulin-like growth factor measurements in the evaluation of growth hormone secretion. Horm Res 1990; 33 Suppl. 4: 25-30
24. Caufriez A, Frankenne F, Hennen G, et al. Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol 1993; 265: E572-7
25. Hansson H, Jørgensen F, Petruson B, et al. Regenerating human nasal mucosa cells express peptide growth factors. Arch Otolaryngol Head Neck Surg 1991; 117: 1368-77
26. Petruson B, Hansson H, Petruson K. Insulinlike growth factor I immunoreactivity in nasal polyps. Arch Otolaryngol Head Neck Surg 1988; 114: 1272-5
27. Lund VJ. International consensus report on the diagnosis and management of rhinitis: International Rhinitis Management Working Group. Allergy 1994; 49 (19 Suppl.): 1-34
28. Skinner DW, Richards SH. Acromegaly: the mucosal changes within the nose and paranasal sinuses. J Laryngol Otol 1988; 102: 1107-10
29. Mabry RL. Rhinitis of pregnancy. South Med J 1986; 79: 965-71
30. Turnbull GL, Rundell OH, Rayburn WE, et al, Managing pregnancy-related nocturnal nasal congestion: the external nasal dilator. J Reprod Med 1996; 41 (12): 897-902
31. Ellegård E, Hellgren M, Torén K, et al. The incidence of pregnancy rhinitis. Gynecol Obstet Invest 2000; 49: 98-101
32. Bende M, Gredmark T. Nasal stuffiness during pregnancy. Laryngoscope 1999; 109: 1108-10
33. Ellegård E, Karlsson G. IgE-mediated reactions and hyperreactivity in pregnancy rhinitis. Arch Otolaryngol Head Neck Surg 1999; 125: 1121-5
34. Ohashi Y, Nakai Y, Tanaka A, et al. Soluble intercellular adhesion molecule-1 level in sera is elevated in perennial allergic rhinitis. Laryngoscope 1997; 107 (7): 932-5
35. Kato M, Hattori T, Kitamura M, et al. Soluble ICAM-1 as a regulator of nasal allergic reaction under natural allergen provocation. Clin Exp Allergy 1995; 25 (8): 744-8
36. Hallén H, Juto JE. A test for objective diagnosis of nasal hyperreactivity. Rhinology 1993; 31: 23-5
37. Sorri M, Hartikainen-Sorri A, Kärjä J. Rhinitis during pregnancy. Rhinology 1980; 18: 83-6
38. Graf P, Hallén H. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride and placebo nasal sprays. Laryngoscope 1996; 106: 605-9
39. Juniper EF. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 1997; 99: S742-9
40. Rundcrantz H. Postural variations of nasal patency. Acta Otolaryngol 1969; 68: 435-43
41. Franklin KA, Holmgren PÅ, Jönsson F, et al. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest 2000; 117: 137-41
42. Lundberg JO, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nat Med 1995; 1: 370-3
43. Lundberg JO, Rinder J, Weitzberg E, et al. Nasally exhaled nitric oxide in humans originates mainly in the paranasal sinuses. Acta Physiol Scand 1994; 152: 431-2
44. Lundberg JO, Lundberg JM, Settergren G, et al. Nitric oxide, produced in the upper airways, may act in an "aerocrine" fashion to enhance pulmonary oxygen uptake in humans. Acta Physiol Scand 1995; 155: 467-8
45. Settergren G, Angdin M, Astudillo R, et al. Decreased pulmonary vascular resistance during nasal breathing: modulation by endogenous nitric oxide from the paranasal sinuses. Acta Physiol Scand 1998; 163: 235-9
46. Heikkila A, Erkkola R. Review of beta-lactam antibiotics in pregnancy: the need for adjustment of dosage schedules. Clin Pharmacokinet 1994; 27 (1): 49-62
47. Graf P, Hallen H, Juto JE. Four-week use of oxymetazoline nasal spray (Nezeril®) once daily at night induces rebound swelling and nasal hyperreactivity. Acta Otolaryngol (Stockh) 1995; 115: 71-5
48. Lekas MD. Rhinitis during pregnancy and rhinitis medicamentosa. Otolaryngol Head Neck Surg 1992; 107: 845-9
49. Onrust SV, Lamb HM. Mometasone furoate: a review of its intranasal use in allergic rhinitis. Drugs 1998; 56 (4): 725-45
50. Storms WW. Risk-benefit assessment of fluticasone propionate in the treatment of asthma and allergic rhinitis. J Asthma 1999; 35 (4): 313-36
51. Lildholdt T, Rundcrantz H, Bende M, et al. Glucocorticoid treatment for nasal polyps: the use of topical budesonide powder, intramuscular betamethasone, and surgical treatment. Arch Otolaryngol Head Neck Surg 1997; 123: 595-600
52. Hallen H, Enerdal J, Graf P. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa. Clin Exp Allergy 1997; 27: 552-8
53. Scadding GK, Lund VJ, Jacques LA, et al. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis. Clin Exp Allergy 1995; 25 (8): 737-43
54. Ellegård EK, Hellgren M, Karlsson NG. Fluticasone propionate aqueous nasal spray in pregnancy rhinitis. Clin Otolaryngol 2001; 26 (5): 394-400
55. Källén B, Rydhstroem H, Åberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol 1999; 93: 392-5